Altered NCR3 Splice Variants May Result in Deficient NK Cell Function in Renal Cell Carcinoma Patients
In Vivo · 2024
DOI: 10.21873/invivo.13423 ↗Kurz gefasst
Fachartikel in der Zeitschrift In Vivo, 2024. Verfasst von Xuelei Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, P.R. China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, P.R. China.
- Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, P.R. China zhengjh0471@sina.com.
Zitieren
APA
Wang, X., Huang, L., Wen, X., Li, D., Yang, G., & Zheng, J. (2024). Altered NCR3 Splice Variants May Result in Deficient NK Cell Function in Renal Cell Carcinoma Patients. In Vivo. https://doi.org/10.21873/invivo.13423
Vancouver
Wang X, Huang L, Wen X, Li D, Yang G, Zheng J. Altered NCR3 Splice Variants May Result in Deficient NK Cell Function in Renal Cell Carcinoma Patients. In Vivo. 2024. doi:10.21873/invivo.13423
BibTeX
@article{Wang2024,
author = {Wang, Xuelei and Huang, Liqun and Wen, Xiaofei and Li, Dongyang and Yang, Guosheng and Zheng, Junhua},
title = {Altered NCR3 Splice Variants May Result in Deficient NK Cell Function in Renal Cell Carcinoma Patients},
journal = {In Vivo},
year = {2024},
doi = {10.21873/invivo.13423}
}
EUVIMED